Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stratified Therapy on Pediatric AAGN Based on Risk Assessment-A Prospective, Multicenter, Open, Tendentious Matched Control Clinical Study

NCT05969522 is registered in ClinicalTrials.gov with Wang Mo as lead sponsor.

NCT NCT05969522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stratified Therapy on Pediatric AAGN Based on Risk Assessment-A Prospective, Multicenter, Open, Tendentious Matched Control Clinical Study
Lead sponsor
Wang Mo
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2023
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anca-associated glomerulonephritis, anti-neutrophil cytoplasmic antibody-associated vasculitis